2Kurosumi M,Tabei T,Suemasu K. Enhancement of immunohistochemical reactivity for thymidine phos-phorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients[J].{H}Oncology Reports,2000,(05):945-948.
3Miller DS,Blessing JA,Krasner CN. Phase II evalu-ation of pemetrexed in the treatment of recurrent or per-sistent platinum-resistant ovarian or primary peritoneal carcinoma:a study of the Gynecologic Oncology Group[J].{H}Journal of Clinical Oncology,2009,(16):2686-2691.
4Rollins KD,Lindley C. Pemetrexed:a multitargeted anti-folate[J].{H}Clinical Therapeutice,2005,(09):1343-1382.
5Yuichiro O. Chemoradiotherapy for lung cancer[J].Ex-pert Opin Pharmacother,2005,(16):2793-2804.
6Kennedy B,Gargoum F,Bystricky B. Novel agents in the management of lung cancer[J].{H}Current Medicinal Chemistry,2010,(35):4291-4325.
7Jenal A, Bray F, Cemer MM, et al. Global cancer statistics [J]. Cancer J Clin,2011,61(2) : 134-135.
